| Innovent Biologics | Commercial | $142.2B | Oncology, Metabolic Disorders |
| Genocury Biotech | preclinical | — | Oncology |
| VivaVision Biotech | commercial | — | Ophthalmology |
| Tenacia Biotechnology | phase-1 | — | Oncology, Immunology |
| Ocumension Therapeutics | phase-2 | — | Ophthalmology |
| Nuance Pharma | commercial | — | Respiratory, Cardiovascular |
| Lyvgen Pharma | phase-2 | — | Oncology, Immunology |
| Lepu Biopharma | phase-2 | — | Oncology, Immunology |
| InventisBio | phase-2 | — | Oncology, Metabolic Diseases |
| Immorna Biotherapeutics | preclinical | — | Infectious Diseases, Oncology |
| Laekna Therapeutics | phase-2 | — | Oncology |
| Dizal Pharma | phase-2 | — | Oncology, Immunology |
| GenFleet Therapeutics | phase-2 | — | Oncology, Immunology |
| Full-Life Technologies | phase-2 | — | Oncology |
| EpimAb Biotherapeutics | phase-2 | — | Oncology, Immunology |
| Duality Biologics | phase-1 | — | Oncology |
| Drug Farm | preclinical | — | Infectious Disease, Oncology |
| CStone Pharmaceuticals | commercial | — | Oncology, Immunology |
| Convalife Pharmaceuticals | phase-2 | — | Cardiovascular, Metabolic |
| Abbisko Therapeutics | phase-2 | — | Oncology |
| Broncus Medical | Commercial | — | Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer |
| Biocytogen | Pre-clinical | — | Oncology, Immunology |
| Thousand Oaks Biopharmaceuticals | phase-2 | — | Oncology, Immunology |
| Vazyme | commercial | — | Diagnostics |
| Vazyme | commercial | — | Diagnostics |
| TransThera Sciences | phase-2 | — | Oncology, Immunology |
| Eaglenos Sciences | preclinical | — | Oncology |
| Biosion | phase-2 | — | Oncology, Immunology |
| HighTide Therapeutics | phase-3 | — | Metabolic |
| Viva Biotech | platform | — | Oncology, Infectious Disease |
| Quaero Life Science | phase-2 | — | Oncology, Immunology |
| AccuPulse | commercial | — | Cardiovascular, Respiratory |
| Innorna | preclinical | — | Genetics & Genomics, Oncology |
| APRINOIA Therapeutics | phase-2 | — | Neuroscience, Diagnostics |
| Yirui Pharma | phase-2 | — | Oncology, Immunology |
| Sciwind Biosciences | phase-2 | — | Metabolic |
| Lynk Pharmaceuticals | phase-2 | — | Oncology, Immunology |
| HighField Biopharmaceuticals | phase-2 | — | Oncology, Immunology |
| Xiangxue Life Sciences | phase-2 | — | Oncology |
| MingMed Biotechnology | phase-2 | — | Oncology, Immunology |
| Excelmab | phase-2 | — | Oncology, Immunology |
| Fapon Biotech | platform | — | Diagnostics, Biologics (as a service provider) |
| Sintaho Pharmaceutical | phase-2 | — | Oncology, Immunology |
| Keymed Biosciences | phase-2 | — | Oncology, Immunology |
| TransGen Biotech | platform | — | Oncology, Infectious Disease |
| Surgerii Robotics | commercial | — | Surgery, Urology |
| MegaRobo | platform | — | AI / Machine Learning, Drug Delivery |
| InnoCare | commercial | — | Oncology, Immunology |
| Genetron Health | commercial | — | Oncology, Diagnostics |
| Coyote Bioscience | commercial | — | Infectious Disease, Diagnostics |
| BroadenBio | phase-2 | — | Oncology, Immunology |
| AffaMed Therapeutics | phase-3 | — | Ophthalmology, Neuroscience |
| Avistone | phase-2 | — | Oncology |
| Tianhu Technology | preclinical/platform | — | Oncology, Immunology |
| CSR Biotech | phase-2 | — | Oncology, Immunology |